These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 3534713

  • 1. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
    Rouhan D, Le Noc P, Le Noc D.
    Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
    [Abstract] [Full Text] [Related]

  • 2. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P, Bryskier A, Le Noc D.
    Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL, Jacobus NV, Tally FP, Gorbach SL.
    Clin Ther; 1983 May; 5(6):603-16. PubMed ID: 6313195
    [Abstract] [Full Text] [Related]

  • 4. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P, Bryskier A, Le Noc D.
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [Abstract] [Full Text] [Related]

  • 5. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO, Bryskier A, Izard D, Leclerc H.
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [Abstract] [Full Text] [Related]

  • 6. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R, Gutmann L, Kitzis MD, Goldstein F, Acar JF.
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [Abstract] [Full Text] [Related]

  • 7. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
    Jarlier V, Bismuth R, Grosset J.
    Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393
    [Abstract] [Full Text] [Related]

  • 8. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
    Thabaut A, Meyran M, Huerre M.
    Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
    [Abstract] [Full Text] [Related]

  • 9. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
    Berche P, Gaillard JL.
    Ann Biol Clin (Paris); 1986 May; 44(6):624-7. PubMed ID: 3826779
    [Abstract] [Full Text] [Related]

  • 10. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
    Norris SM, Guenthner SH, Wenzel RP.
    J Antimicrob Chemother; 1985 Aug; 16(2):183-8. PubMed ID: 3934124
    [Abstract] [Full Text] [Related]

  • 11. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
    Le Noc P, Bryskier A, Le Noc D.
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
    Bartmann K, Tarbuc R.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S, Hiraoka M, Inoue M, Tomatsu K, Hirano M, Mitsuhashi S.
    Drugs Exp Clin Res; 1989 Dec; 15(1):1-10. PubMed ID: 2663406
    [Abstract] [Full Text] [Related]

  • 14. Comparative in vitro evaluation of BMY-28142, a new broad-spectrum cephalosporin, versus other beta-lactams against multiresistant gram-negative isolates.
    Giamarellou H, Sahin A, Chryssouli Z.
    Drugs Exp Clin Res; 1987 Dec; 13(3):149-53. PubMed ID: 3622243
    [Abstract] [Full Text] [Related]

  • 15. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L, Le Van Thoi J, Soussy CJ, Duval J.
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [Abstract] [Full Text] [Related]

  • 16. [Inhibition of cephalosporinase of enterobacteria by ceftriaxone].
    Péchinot A, Duez JM, Nordmann P, Kazmierczak A, Labia R.
    Pathol Biol (Paris); 1986 May; 34(5):399-403. PubMed ID: 3534712
    [Abstract] [Full Text] [Related]

  • 17. [Ceftizoxime: in vitro evaluation].
    Fernández AJ, de Mier CA, Herran IL, Marcenac F.
    Medicina (B Aires); 1989 May; 49(5):533-6. PubMed ID: 2487423
    [Abstract] [Full Text] [Related]

  • 18. Influence of cefmenoxime, ceftriaxone, latamoxef, and ceftazidime on the lysis of Klebsiella pneumoniae: a light and electron microscopic study.
    Ullmann U, Hammer-Uschtrin U.
    Am J Med; 1984 Dec 21; 77(6A):21-4. PubMed ID: 6083724
    [Abstract] [Full Text] [Related]

  • 19. In-vitro studies with ceftazidime.
    Giamarellou H, Avlami A, Matsakas V, Kosmidis J, Daikos GK.
    J Antimicrob Chemother; 1981 Sep 21; 8 Suppl B():73-7. PubMed ID: 19802972
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.